{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:44:19Z","timestamp":1761155059498},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.critrevonc.2007.06.008","type":"journal-article","created":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T08:57:35Z","timestamp":1185958655000},"page":"73-81","source":"Crossref","is-referenced-by-count":17,"title":["An open multicenter phase II trial of docetaxel\u2013gemcitabine in Charlson score and performance status (PS) selected elderly patients with stage IIIB pleura\/IV non-small-cell lung cancer (NSCLC): The GFPC 02-02a study"],"prefix":"10.1016","volume":"64","author":[{"given":"H.","family":"LeCaer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Fournel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Jullian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Chouaid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"LeTreut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Paillotin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Perol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Gimenez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Vergnenegre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2007.06.008_bib1","unstructured":"Balducci L. Lung cancer and aging. ASCO 2005. Educational book. p. 587\u201391."},{"key":"10.1016\/j.critrevonc.2007.06.008_bib2","first-page":"691","article-title":"Primary bronchial carcinoma in elderly subjects in France","volume":"20","author":"Piquet","year":"2003","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.critrevonc.2007.06.008_bib3","doi-asserted-by":"crossref","first-page":"9113","DOI":"10.1200\/JCO.2005.03.7465","article-title":"Should elderly non-small-cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group","volume":"23","author":"Jatoi","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2007.06.008_bib4","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1634\/theoncologist.5-3-224","article-title":"Management of cancer in the older person: a practical approach","volume":"5","author":"Balducci","year":"2000","journal-title":"Oncologist"},{"key":"10.1016\/j.critrevonc.2007.06.008_bib5","doi-asserted-by":"crossref","first-page":"ii58","DOI":"10.1093\/annonc\/mdj925","article-title":"Chemotherapy of advanced non-small-cell lung cancer in elderly patients","volume":"17","author":"Rossi","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.critrevonc.2007.06.008_bib6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/jnci\/91.1.66","article-title":"Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer","volume":"91","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.critrevonc.2007.06.008_bib7","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1200\/JCO.2005.00.224","article-title":"Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel","volume":"23","author":"Gridelli","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2007.06.008_bib8","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1200\/JCO.2000.18.13.2529","article-title":"Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer","volume":"18","author":"Frasci","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2007.06.008_bib9","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/jnci\/95.5.362","article-title":"Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial","volume":"95","author":"Gridelli","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.critrevonc.2007.06.008_bib10","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3816\/CLC.2005.n.026","article-title":"Multicenter phase II trial of carboplatin\/vinorelbine in elderly patients with advanced non-small-cell lung cancer efficacy and impact on quality of life: Groupe Francais de Pneumo-Cancerologie Study 9902","volume":"7","author":"LeCaer","year":"2005","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.critrevonc.2007.06.008_bib11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.lungcan.2004.05.015","article-title":"Results of a phase II multicenter trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small-cell lung cancer","volume":"47","author":"Neubauer","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1016\/j.critrevonc.2007.06.008_bib12","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.critrevonc.2006.04.001","article-title":"Comorbid illnesses and health care utilization among medicare beneficiaries with lung cancer","volume":"59","author":"Dy","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.critrevonc.2007.06.008_bib13","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","article-title":"Validation of a combined comorbidity index","volume":"47","author":"Charlson","year":"1994","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.critrevonc.2007.06.008_bib14","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1040-8428(01)00145-7","article-title":"Chemotherapy of lung cancer in the elderly","volume":"41","author":"Frasci","year":"2002","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.critrevonc.2007.06.008_bib15","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0360-3016(01)02741-9","article-title":"Comorbidity, and KPS are independent prognostic factors in stage I non-small-cell lung cancer","volume":"52","author":"Firat","year":"2002","journal-title":"Int J Radiat Biol Phys"},{"key":"10.1016\/j.critrevonc.2007.06.008_bib16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0093-7754(01)90221-0","article-title":"Weekly docetaxel as a single agent and in combination with gemcitabine in elderly and poor performance status patients with advanced non-small-cell lung cancer","volume":"28","author":"Hainsworth","year":"2001","journal-title":"Semin Oncol"},{"key":"10.1016\/j.critrevonc.2007.06.008_bib17","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.critrevonc.2007.06.008_bib18","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0021-9681(81)90058-8","article-title":"Measuring the quality of life of cancer patients: a concise QL-index for use by physicians","volume":"34","author":"Spitzer","year":"1981","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.critrevonc.2007.06.008_bib19","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1002\/1097-0142(19940415)73:8<2087::AID-CNCR2820730813>3.0.CO;2-X","article-title":"Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies psychometric assessment of the Lung Cancer Symptom Scale","volume":"73","author":"Hollen","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2007.06.008_bib20","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0021-9681(61)90060-1","article-title":"The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent","volume":"13","author":"Gehan","year":"1961","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.critrevonc.2007.06.008_bib21","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00000421-200210000-00017","article-title":"Phase II study of docetaxel and gemcitabine combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy","volume":"25","author":"Chen","year":"2002","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2007.06.008_bib22","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.lungcan.2003.12.004","article-title":"High incidence of pulmonary toxicity of weekly docetaxel and gemcitabine in patient with non-small-cell lung cancer: results of a dose-finding study","volume":"44","author":"Kouroussis","year":"2004","journal-title":"Lung Cancer"},{"key":"10.1016\/j.critrevonc.2007.06.008_bib23","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1200\/JCO.2001.19.11.2865","article-title":"Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial","volume":"19","author":"Littlewood","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2007.06.008_bib24","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.lungcan.2005.10.023","article-title":"A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small-cell lung cancer (NSCLC)","volume":"51","author":"Giorgio","year":"2006","journal-title":"Lung Cancer"},{"key":"10.1016\/j.critrevonc.2007.06.008_bib25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.lungcan.2004.08.012","article-title":"First line chemotherapy with gemcitabine in advanced non-small-cell lung cancer elderly patients: a randomized phase II study of 3-week versus 4-week schedule","volume":"47","author":"Quoix","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1016\/j.critrevonc.2007.06.008_bib26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.lungcan.2004.11.029","article-title":"Sequential therapy with vinorelbine followed by gemcitabine in patients with metastatic non-small-cell lung cancer (NSCLC) performance status (PS) 2 or elderly with comorbidities\u2014a multicenter phase II trial","volume":"49","author":"Hirsh","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1016\/j.critrevonc.2007.06.008_bib27","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.lungcan.2006.05.013","article-title":"Gemcitabine and vindesine in advanced non-small-cell lung cancer: a phase II study in elderly or poor performance status patients","volume":"53","author":"Santo","year":"2006","journal-title":"Lung Cancer"},{"key":"10.1016\/j.critrevonc.2007.06.008_bib28","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/annonc\/mdi126","article-title":"Gemcitabine\u2013docetaxel versus cisplatin\u2013vinorelbin in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatin","volume":"16","author":"Pujol","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.critrevonc.2007.06.008_bib29","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1200\/JCO.2002.12.112","article-title":"Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in advanced non-small-cell lung cancer: a phase III randomized trial","volume":"20","author":"Kosmidis","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2007.06.008_bib30","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1200\/JCO.2004.10.576","article-title":"Randomized phase III stydy of gemcitabine and vinorebin versus gemcitabine, vinorelbin, and cisplatin in the treatment of advanced non-small-cell lung cancer: from the German and Swiss Lung Cancer Study Group","volume":"22","author":"Laack","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2007.06.008_bib31","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ctrv.2006.07.003","article-title":"Weekly docetaxel as second line chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials","volume":"32","author":"Bria","year":"2006","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.critrevonc.2007.06.008_bib32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0169-5002(02)00145-9","article-title":"A phase II study of weekly gemcitabine and paclitaxel in patients with previously untreated stage IIIB and IV non-small-cell lung cancer","volume":"38","author":"Bhatia","year":"2002","journal-title":"Lung Cancer"},{"key":"10.1016\/j.critrevonc.2007.06.008_bib33","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0761-8425(06)71596-0","article-title":"Lung cancer in the elderly: performance status and\/or geriatric indice?","volume":"23","author":"Dujon","year":"2006","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.critrevonc.2007.06.008_bib34","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1200\/JCO.2004.08.040","article-title":"Differential prognostic impact of comorbidity","volume":"22","author":"Read","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2007.06.008_bib35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1040-8428(03)00099-4","article-title":"A comprehensive geriatric intervention detects multiple problems in older breast cancer patients","volume":"49","author":"Extermann","year":"2004","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.critrevonc.2007.06.008_bib36","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.critrevonc.2005.06.003","article-title":"Use of comprehensive assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG)","volume":"55","author":"Extermann","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.critrevonc.2007.06.008_bib37","doi-asserted-by":"crossref","first-page":"6865","DOI":"10.1200\/JCO.2005.02.527","article-title":"Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study","volume":"23","author":"Maione","year":"2005","journal-title":"J Clin Oncol"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842807001187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842807001187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T13:03:28Z","timestamp":1556715808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842807001187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S1040842807001187"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2007.06.008","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}